Media

Learn more about us in our featured news stories and insights into the work that we do.

News Press Releases Locus Insights

February 20, 2019

Living Medicines: Engineering the Microbiome : SynBioBeta

Learn More
January 16, 2019

Wired: Antibiotics are Failing Us. CRISPR is Our Glimmer of Hope

Learn More
January 9, 2019

BioPharma Reporter: Janssen offers $818m to access CRISPR tech

Learn More
January 4, 2019

Microbiome Times: Locus Biosciences Enters Collaboration and License Agreement with J&J to Develop CRISPR-Cas3 Bacteriophage Therapeutics

Learn More
January 4, 2019

Pharmaceutical Technology: Janssen signs a $818m CRISPR products deal with Locus Biosciences

Learn More
January 3, 2019

Fierce Biotech: J&J takes stake in Locus’ CRISPR-based ‘Pac-Man’ antimicrobials

Learn More
January 3, 2019

Seeking Alpha: J&J teams up with Locus Biosciences to develop CRISPR-based therapies for infections

Learn More
January 3, 2019

BioSpace: Locus and Janssen Ink Potential $818 Million Deal to Develop CRISPR-Based Antibacterials

Learn More
January 3, 2019

WRAL TechWire: Locus Biosciences lands $20M upfront, could earn nearly $800M in licensing deal

Learn More
January 3, 2019

Bloomberg: J&J Bets $20 Million on DNA Tool to Battle Infectious Bacteria

Learn More

Careers

We are on a mission to revolutionize the treatment of disease. We need intelligent, open, hard-working people who thrive in a fast-paced environment to join us on our quest.